GB201403899D0 - Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders - Google Patents

Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders

Info

Publication number
GB201403899D0
GB201403899D0 GB201403899A GB201403899A GB201403899D0 GB 201403899 D0 GB201403899 D0 GB 201403899D0 GB 201403899 A GB201403899 A GB 201403899A GB 201403899 A GB201403899 A GB 201403899A GB 201403899 D0 GB201403899 D0 GB 201403899D0
Authority
GB
United Kingdom
Prior art keywords
quercetin
polyphosphate
treatment
bone disorders
synergistic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201403899A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MULLER WERNER E L
Original Assignee
MULLER WERNER E L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MULLER WERNER E L filed Critical MULLER WERNER E L
Priority to GB201403899A priority Critical patent/GB201403899D0/en
Publication of GB201403899D0 publication Critical patent/GB201403899D0/en
Priority to PCT/EP2015/054523 priority patent/WO2015132304A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB201403899A 2014-03-05 2014-03-05 Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders Ceased GB201403899D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201403899A GB201403899D0 (en) 2014-03-05 2014-03-05 Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders
PCT/EP2015/054523 WO2015132304A1 (fr) 2014-03-05 2015-03-04 Composition synergique comprenant de la quercétine et du polyphosphate pour le traitement de troubles osseux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201403899A GB201403899D0 (en) 2014-03-05 2014-03-05 Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders

Publications (1)

Publication Number Publication Date
GB201403899D0 true GB201403899D0 (en) 2014-04-16

Family

ID=50490843

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201403899A Ceased GB201403899D0 (en) 2014-03-05 2014-03-05 Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders

Country Status (2)

Country Link
GB (1) GB201403899D0 (fr)
WO (1) WO2015132304A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2535450A (en) * 2015-02-09 2016-08-24 Ernst Ludwig Georg Muller Werner Synergistically acting amorphous calcium-polyphosphate nanospheres containing encapsulated retinol for therapeutic applications
CN112403522B (zh) * 2020-11-12 2021-11-23 江南大学 介孔槲皮素锆催化剂及其在制备α，β-不饱和醇中的应用
CN114569797B (zh) * 2022-04-29 2022-12-20 中南大学湘雅医院 一种含槲皮素、氧化镁的人工骨膜、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478579A (en) * 1991-02-06 1995-12-26 Biodyn Medical Research, Inc. Method for treatment of osteoporosis
KR100408231B1 (ko) * 2000-08-14 2003-12-01 한국 한의학 연구원 골다공증 예방 및 치료용 플라보노이드 유도체
EP2489346A1 (fr) * 2011-01-26 2012-08-22 NanotecMARIN GmbH Complément alimentaire et matériau injectable pour la prévention et le traitement de l'ostéoporose et autres maladies osseuses

Also Published As

Publication number Publication date
WO2015132304A1 (fr) 2015-09-11

Similar Documents

Publication Publication Date Title
ZA201901279B (en) Compositions and methods for treatment of neurological disorders
HK1258205A1 (zh) 用於治療血紅蛋白病的組合物和方法
HK1247838A1 (zh) 骨質疏鬆症的治療
IL259861A (en) Methods and preparations for the treatment of disorders related to seizures
HK1258696A1 (zh) 治療或預防皮膚障礙的新型組合物和方法
HK1252813A1 (zh) 用於治療社交障礙和藥物使用障礙的治療性化合物和組合物
ZA201702884B (en) Compositions and methods for the treatment and prophylaxis of surgical site infections
IL262508A (en) Methods and preparations for the treatment of degenerate bone
HK1258502A1 (zh) 用於治療高胱氨酸尿症的組合物和方法
IL248210A0 (en) Methods and preparations for the treatment of blood vessel malformations
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
HK1258073A1 (zh) 治療細胞質糖原貯積失調的方法和組合物
IL257935A (en) Treatment of bone growth disorders
EP3518951C0 (fr) Compositions et méthodes pour le traitement de l'ostéoporose et des fractures osseuses
GB201403899D0 (en) Synergistic composition comprising quercetin and polyphosphate for treatment of bone disorders
IL258629A (en) Methods and compositions for treating traumatic brain injury
DK3359209T3 (en) Compositions and methods for treatment of bone defects
DK3313207T3 (en) Compositions and methods for the treatment of malnutrition
EP2978452A4 (fr) Compositions et méthodes de traitement de troubles osseux ostéolytiques
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
IL247369A0 (en) Compounds and methods for the treatment of bone diseases
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
GB201521083D0 (en) Compositions for treatment and methods thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)